July 6, 2017 NIAID Funding News
Read this full issue online at https://www.niaid.nih.gov/
NIH announced the 2017 Small Business Innovation Research and Small Business Technology Transfer Omnibus solicitations in a June 5, 2017 Guide notice.
Opportunities and Resources
NIAID seeks to support the identification and development of candidate vaccines and immunoprophylactics against multiple select Gram-negative nosocomial pathogens.
A key step forward in our defense against antimicrobial-resistant bacteria is developing culture-independent, rapid, sensitive, specific medical diagnostics that identify select pathogens and determine their antimicrobial susceptibility and resistance.
NIAID seeks innovative imaging strategies to identify reservoirs in human or animal models that have undergone successful, long-term viral suppression.
In The News
If you missed the June 5, 2017 meeting of NIAID’s advisory Council, you can watch a videocast of remarks from NIAID Director Dr. Anthony Fauci, NIAID Vaccine Research Center Director Dr. John Mascola, and NIH Principal Deputy Director Dr. Lawrence Tabak, as well as open subcommittee sessions.
NIH’s purpose behind implementing the forms change is to consolidate human subjects, inclusion enrollment, and clinical trial information previously collected across multiple agency forms.
- NIAID Raises New-PI R01 Payline, Sets R03 Payline
- Protecting Life in Global Health Assistance Extends Mexico City Policy
- Change of Key Dates for Primary Immunodeficiency Diseases FOAs
Too often, applicants submit grant applications with the statement "not a genome-wide association study" instead of identifying whether their proposed research falls under the NIH Genomic Data Sharing policy.
New Funding Opportunities
See announcements at Opportunities & Announcements.
Send suggestions or comments to email@example.com.